ZA200109516B - Method for preparing dual virally inactivated immune globulin for intravenous administration. - Google Patents

Method for preparing dual virally inactivated immune globulin for intravenous administration.

Info

Publication number
ZA200109516B
ZA200109516B ZA200109516A ZA200109516A ZA200109516B ZA 200109516 B ZA200109516 B ZA 200109516B ZA 200109516 A ZA200109516 A ZA 200109516A ZA 200109516 A ZA200109516 A ZA 200109516A ZA 200109516 B ZA200109516 B ZA 200109516B
Authority
ZA
South Africa
Prior art keywords
intravenous administration
immune globulin
virally inactivated
preparing dual
inactivated immune
Prior art date
Application number
ZA200109516A
Other languages
English (en)
Inventor
Raja R Mamidi
Andranik Bagdasarian
Gorgonio Canaveral
Kazuo Takechi
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of ZA200109516B publication Critical patent/ZA200109516B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200109516A 1999-05-20 2001-11-19 Method for preparing dual virally inactivated immune globulin for intravenous administration. ZA200109516B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/316,117 US6441144B1 (en) 1999-05-20 1999-05-20 Method for repairing dual virally inactivated immune globulin for intravenous administration

Publications (1)

Publication Number Publication Date
ZA200109516B true ZA200109516B (en) 2002-11-06

Family

ID=23227544

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109516A ZA200109516B (en) 1999-05-20 2001-11-19 Method for preparing dual virally inactivated immune globulin for intravenous administration.

Country Status (13)

Country Link
US (2) US6441144B1 (ja)
EP (1) EP1183036A4 (ja)
JP (1) JP2003528803A (ja)
KR (1) KR20020019916A (ja)
CN (1) CN1351500A (ja)
AU (1) AU757568B2 (ja)
BR (1) BR0010815A (ja)
CA (1) CA2371356A1 (ja)
CZ (1) CZ20013792A3 (ja)
IL (1) IL146039A0 (ja)
PL (1) PL361133A1 (ja)
WO (1) WO2000071142A1 (ja)
ZA (1) ZA200109516B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995246B1 (en) * 2000-10-19 2006-02-07 Akzo Nobel N.V. Methods for removing suspended particles from soluble protein solutions
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
JP5037331B2 (ja) * 2004-03-19 2012-09-26 バクスター・インターナショナル・インコーポレイテッド 出血性障害の処置のための第ｉｘａ因子
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US20080214795A1 (en) * 2007-02-14 2008-09-04 Amgen Inc. Method of isolating antibodies by precipitation
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
WO2009046168A1 (en) 2007-10-02 2009-04-09 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
WO2010059232A1 (en) * 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
EP2519537A4 (en) * 2009-12-29 2013-07-10 Reddys Lab Ltd Dr CLEANING PROTEINS
HUE053664T2 (hu) 2011-07-18 2021-07-28 The United States Of America Eljárások és készítmények Polyomavírussal összefüggõ betegségek gátlására
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法
EP3313273A4 (en) * 2015-06-24 2019-03-20 The Medical College of Wisconsin, Inc. SYSTEM AND METHOD FOR LOCALIZED PROCESSING OF CARDS OF QUANTITATIVE SUSCEPTIBILITY IN MAGNETIC RESONANCE IMAGING

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4820805A (en) 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
JPS6042336A (ja) * 1983-08-18 1985-03-06 Nippon Seiyaku Kk 免疫グロブリンの製造方法
US4835257A (en) 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
FR2582515B1 (fr) 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4841023A (en) 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
CA1310267C (en) 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
DE3825429C2 (de) 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
JP2926728B2 (ja) * 1988-12-29 1999-07-28 吉富製薬株式会社 蛋白質含有組成物の製造方法
JP2965069B2 (ja) * 1989-01-13 1999-10-18 吉富製薬株式会社 蛋白質含有組成物の製造方法
EP0378208B2 (en) 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
JP3297433B2 (ja) 1989-06-15 2002-07-02 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド ウイルスで汚染された薬理組成物中のウイルスの不活性化方法
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
JP3145696B2 (ja) 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
US5110910A (en) 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
WO1994017834A1 (de) * 1993-02-09 1994-08-18 Octapharma Ag Verfahren zur inaktivierung von viren, die nicht mit lipidhüllen versehen sind
WO1998030230A1 (fr) * 1997-01-09 1998-07-16 Yoshitomi Pharmaceutical Industries, Ltd. Compositions proteinees et procede de production

Also Published As

Publication number Publication date
CZ20013792A3 (cs) 2002-04-17
BR0010815A (pt) 2002-06-11
CA2371356A1 (en) 2000-11-30
JP2003528803A (ja) 2003-09-30
EP1183036A4 (en) 2004-12-01
EP1183036A1 (en) 2002-03-06
PL361133A1 (en) 2004-09-20
US6441144B1 (en) 2002-08-27
CN1351500A (zh) 2002-05-29
US20010044524A1 (en) 2001-11-22
US6504012B2 (en) 2003-01-07
IL146039A0 (en) 2002-07-25
KR20020019916A (ko) 2002-03-13
AU4641000A (en) 2000-12-12
WO2000071142A1 (en) 2000-11-30
AU757568B2 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
ZA200000842B (en) Method and system for administering a medication.
ZA99104B (en) Method for administering ASPB28-human insulin.
MXPA03007319A (es) Anticuerpos contra egfr modificados, con inmunogenicidad reducida.
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
HK1043731A1 (en) Vaccine against antigens from bacteriae
ZA964614B (en) Methods for the preparation of substantially monomeric callcheamicin derivative carrier conjugates.
HK1042245A1 (en) Pharmaceutical moxifloxacin preparation.
ZA200109516B (en) Method for preparing dual virally inactivated immune globulin for intravenous administration.
MXPA01011312A (es) Silla para bebe.
HK1044342A1 (en) Method for the preparation of 5-cyanophthalide.
EP1337149A4 (en) VACCINE IMMUNOTHERAPY FOR IMMUNE-PATIENT PATIENTS
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
NO882841D0 (no) Vakuum-emballasje, saerlig for kaffe.
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
EP0878541A4 (en) ROTAVIRUS ANTIGENS, VACCINES AND MEDICINES FOR DIAGNOSING ROTAVIRUS INFECTION AND METHODS OF PREPARING THE SAME
FR2669346B1 (fr) Vaccin a poxvirus recombinant contre le virus de la rougeole.
ZA200300743B (en) DDS compound and process for the preparation thereof.
AU2001270934A1 (en) A method for correcting the immune system of live body
HUP0001069A3 (en) Method for producing an igm preparation for intravenous administration
HUP9602262A2 (en) Prostaglandin derivatives, pharmaceutical compns. contg. them and process for preparing the said compds.
MXPA02000958A (es) Estrategia novedosa para vacunas terapeuticas basadas en hidratos de carbono.
WO2001034184A3 (en) Methods and compositions for protection against bovine herpesvirus 1
WO2002041921A3 (en) Compositions for protection against bovine viral diseases
ZA200110454B (en) Pharmaceutical complex.
FR2715304B1 (fr) Vaccin anti-allergique.